Skip to Main Content

Contact Information

Sylvester Comprehensive Cancer Center 3rd floor
Donald T. Weed, M.D.

Donald T. Weed, M.D.

  • Professor
  • Co-Leader Head and Neck Site Disease Group President Medical Staff, University of Miami Hospital and Clinics
  • Otolaryngology
Research InterestPage 1
Dr. Weed investigates novel methods to reverse tumor induced immune suppression in patients with head and neck squamous cell carcinoma. His collaborative team has designed clinical trials investigating the use of a phosphodiesterase 5 inhibitor (Tadalafil) as an immunomodulator in patients with recurrent head and neck cancer and has a currently open clinical trial utilizing tadalafil and an anti-tumor vaccine (anti-MUC1) in this same patient population. A new trial is being designed combining a checkpoint inhibitor with this treatment strategy.